CXCL13 and cancer: The analysis revealed significant differences in CXCL13 expression across 24 tumors, with higher CXCL13 expression levels found in 22 cancer types (ACC, BRCA, CESC, CHOL, COAD, GBM, ESCA, HNSC, KIRC, LAML, LGG, LIHC, LUAD, LUSC, OV, SKCM, STAD, PAAD, TGCT, THCA, UCEC, and UCS) and lower expression in two cancer types (PRAD and READ) compared to the normal tissues (Figure 1C).